Chemoinformaics analysis of Isoswertisin 5-O-glucoside
| Molecular Weight | 608.549 | nRot | 7 |
| Heavy Atom Molecular Weight | 576.293 | nRig | 30 |
| Exact Molecular Weight | 608.174 | nRing | 5 |
| Solubility: LogS | -3.573 | nHRing | 3 |
| Solubility: LogP | -0.715 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
| nHA | 15 | APOL | 80.1274 |
| nHD | 9 | BPOL | 41.6506 |
| QED | 0.139 |
| Synth | 4.707 |
| Natural Product Likeliness | 1.728 |
| NR-PPAR-gamma | 0.605 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.986 |
| HIA | 0.974 |
| CACO-2 | -6.337 |
| MDCK | 0.000123242 |
| BBB | 0.437 |
| PPB | 0.599346 |
| VDSS | 0.655 |
| FU | 0.272185 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.03 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.104 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.489 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.156 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.005 |
| CL | 1.422 |
| T12 | 0.269 |
| hERG | 0.017 |
| Ames | 0.598 |
| ROA | 0.081 |
| SkinSen | 0.008 |
| Carcinogencity | 0.182 |
| EI | 0.004 |
| Respiratory | 0.012 |
| NR-Aromatase | 0.946 |
| Antiviral | Yes |
| Prediction | 0.857149 |